Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Peritoneal Neoplasms 2Gastric Adenocarcinoma 2Stomach Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ovarian Epithelial Cancer Recurrent 1Neoplasms 1Neoplasm Metastasis 1Locally Advanced Gastric Cancer 1Krukenberg Tumor 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

S 1 (combination) 1Oxaliplatin 1Hyperthermic Intraperitoneal Chemotherapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Gastric Cancer × Hyperthermic Intraperitoneal Chemotherapy × 90 days × Clear all
NCT07621484 2026-06-02

HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer

Shanghai Changzheng Hospital

Phase 2 Not yet recruiting
48 enrolled
Gastrointestinal

Locally Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡